Comparative evaluation of the efficacy and safety of Dexmedetomedine on patients with and without Î² blocker posted for Vitreo Retinal surgery under intravenous sedation and peribulbar block - .

ETHRADHAMA SUPER SPECIALITY EYE HOSPITA0 sites0 target enrollmentTBD

ConditionsHealth Condition 1: null- Retinal Disorder Patients requiring SurgeryHealth Condition 2: H431- Vitreous hemorrhage

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: null- Retinal Disorder Patients requiring SurgeryHealth Condition 2: H431- Vitreous hemorrhage
Sponsor: ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
Status: Active, not recruiting
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Observational

Investigators

Sponsor

ETHRADHAMA SUPER SPECIALITY EYE HOSPITA

Eligibility Criteria

Inclusion Criteria

•1\. Patients aged 40 to 75 years
•2\. ASA grade 1 to 3
•3\. Elective procedures posted for vitreo retinal surgery

Exclusion Criteria

•1\. Age \> 70 years
•2\. Severe left ventricular dysfunction (Ejection fraction \< 35 %)
•3\. Baseline heart rate \< 40 bpm
•4\. Hypovolemia with systolic blood pressure \< 90 mmHg
•5\. Second and third degree heart block
•6\. Chronic renal failure and hepatic impairment
•7\. Bleeding or coagulation abnormalities
•8\. Psychiatric diseases
•9\. H/o allergy to the drug

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting

Phase 3

Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1

IRCT20130812014333N145Kermanshah University of Medical Sciences80

Recruiting

Phase 3

Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19

IRCT20130812014333N147Kermanshah University of Medical Sciences80

Recruiting

Phase 2

evaluation the effect of botulinum toxin type A for treating frown linesskin rejuvenation.

IRCT20150101020514N8Imen vaccine alborz Company140

Completed

Not Applicable

Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial.overactive bladder

JPRN-UMIN000004354Department of Urology, Kanto Rosai Hospital60

Recruiting

Phase 4

Study to compare which iron preparations is better for treatment of anaemic in patients of chronic kidney disease.

CTRI/2017/08/009343Jawaharlal Nehru Medical College Hospital